These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
463 related articles for article (PubMed ID: 30230950)
1. Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women. Marsh EE; Al-Hendy A; Kappus D; Galitsky A; Stewart EA; Kerolous M J Womens Health (Larchmt); 2018 Nov; 27(11):1359-1367. PubMed ID: 30230950 [TBL] [Abstract][Full Text] [Related]
3. Impact of diagnosis and treatment of uterine fibroids on quality of life and labor productivity: The Japanese online survey for uterine fibroids and quality of life (JOYFUL survey). Koga K; Fukui M; Fujisawa M; Suzukamo Y J Obstet Gynaecol Res; 2023 Oct; 49(10):2528-2537. PubMed ID: 37524334 [TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids. Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study. Chen J; Li Y; Wang Z; McCulloch P; Hu L; Chen W; Liu G; Li J; Lang J; BJOG; 2018 Feb; 125(3):354-364. PubMed ID: 28421665 [TBL] [Abstract][Full Text] [Related]
6. Alternatives to hysterectomy: The burden of fibroids and the quality of life. Fortin C; Flyckt R; Falcone T Best Pract Res Clin Obstet Gynaecol; 2018 Jan; 46():31-42. PubMed ID: 29157931 [TBL] [Abstract][Full Text] [Related]
7. Burden of symptomatic uterine fibroids in Canadian women: a cohort study. Laberge PY; Vilos GA; Vilos AG; Janiszewski PM Curr Med Res Opin; 2016; 32(1):165-75. PubMed ID: 26455364 [TBL] [Abstract][Full Text] [Related]
8. Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research. Coyne KS; Margolis MK; Murphy J; Spies J Value Health; 2012; 15(5):674-9. PubMed ID: 22867776 [TBL] [Abstract][Full Text] [Related]
9. The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL). Harding G; Coyne KS; Thompson CL; Spies JB Health Qual Life Outcomes; 2008 Nov; 6():99. PubMed ID: 19014505 [TBL] [Abstract][Full Text] [Related]
10. A systematic review of the psychosocial impact of fibroids before and after treatment. Go VAA; Thomas MC; Singh B; Prenatt S; Sims H; Blanck JF; Segars JH Am J Obstet Gynecol; 2020 Nov; 223(5):674-708.e8. PubMed ID: 32474012 [TBL] [Abstract][Full Text] [Related]
11. The Impact of Fertility Goals on Long-term Quality of Life in Reproductive-aged Women Who Underwent Myomectomy versus Hysterectomy for Uterine Fibroids. Frisch EH; Mitchell J; Yao M; Llarena N; Omosigho UR; DeAngelo L; Arakelian M; Bradley L; Falcone T J Minim Invasive Gynecol; 2023 Aug; 30(8):642-651. PubMed ID: 37044261 [TBL] [Abstract][Full Text] [Related]
12. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial. de Bruijn AM; Ankum WM; Reekers JA; Birnie E; van der Kooij SM; Volkers NA; Hehenkamp WJ Am J Obstet Gynecol; 2016 Dec; 215(6):745.e1-745.e12. PubMed ID: 27393268 [TBL] [Abstract][Full Text] [Related]
13. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials. Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A Am J Obstet Gynecol; 2023 Mar; 228(3):320.e1-320.e11. PubMed ID: 36370871 [TBL] [Abstract][Full Text] [Related]
14. Uterine fibroids: a review of health-related quality of life assessment. Williams VS; Jones G; Mauskopf J; Spalding J; DuChane J J Womens Health (Larchmt); 2006 Sep; 15(7):818-29. PubMed ID: 16999637 [TBL] [Abstract][Full Text] [Related]
15. Impact of uterine fibroids on quality of life: a national cross-sectional survey. Hervé F; Katty A; Isabelle Q; Céline S Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():32-37. PubMed ID: 30099225 [TBL] [Abstract][Full Text] [Related]
16. Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study. Stewart EA; Al-Hendy A; Lukes AS; Madueke-Laveaux OS; Zhu E; Proehl S; Schulmann T; Marsh EE Am J Obstet Gynecol; 2024 Feb; 230(2):237.e1-237.e11. PubMed ID: 37863160 [TBL] [Abstract][Full Text] [Related]
17. Validation of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) Questionnaire. Coyne KS; Soliman AM; Margolis MK; Thompson CL; Chwalisz K Curr Med Res Opin; 2017 Feb; 33(2):193-200. PubMed ID: 27733082 [TBL] [Abstract][Full Text] [Related]
18. Changes in symptom burden and quality of life among women with uterine fibroids receiving relugolix combination therapy: a plain language summary. Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A J Comp Eff Res; 2024 Aug; 13(8):e230194. PubMed ID: 38934918 [TBL] [Abstract][Full Text] [Related]
19. Perceptions of Ethnoracial Factors in the Management and Treatment of Uterine Fibroids. Orellana M; Riggan KA; DSouza K; Stewart EA; Venable S; Balls-Berry JE; Allyse MA J Racial Ethn Health Disparities; 2022 Aug; 9(4):1184-1191. PubMed ID: 34013445 [TBL] [Abstract][Full Text] [Related]
20. Uterine Fibroid Symptom and Health-related Quality of Life Questionnaire: a Chinese translation and validation study. Yeung SY; Kwok JWK; Law SM; Chung JPW; Chan SSC Hong Kong Med J; 2019 Dec; 25(6):453-459. PubMed ID: 31796639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]